Table 3.
Distribution of Treatment Characteristics According to Gender
| Variables | Male N=71* N (%) | Female N=213* N (%) | p value |
|---|---|---|---|
| Type of surgery | |||
| Radical mastectomy | 70 (98.6) | 162 (76.1) | <0.001 |
| Conservative surgery | 1 (1.4) | 51 (23.9) | |
| Type of axillary approach | |||
| Lymphadenectomy | 64 (90.1) | 170 (79.8) | 0.104 |
| Sentinel lymph node biopsy | 5 (7.0) | 37 (17.4) | |
| No | 2 (2.8) | 6 (2.8) | |
| Neo-adjuvant chemotherapy | |||
| Yes | 12 (16.9) | 64 (30.0) | 0.030 |
| No | 59 (83.1) | 149 (70.0) | |
| Neo-adjuvant radiotherapy | |||
| Yes | 2 (2.8) | 7 (3.3) | 0.845 |
| No | 69 (97.2) | 206 (96.7) | |
| Neo-adjuvant hormone therapy | |||
| Yes | 3 (4.2) | 7 (3.3) | 0.71 |
| No | 68 (95.8) | 206 (96.7) | |
| Adjuvant chemotherapy | |||
| Yes | 32 (45.1) | 82 (38.5) | 0.328 |
| No | 39 (54.9) | 131 (61.5) | |
| Adjuvant radiotherapy | |||
| Yes | 31 (43.7) | 128 (60.1) | 0.019 |
| No | 40 (56.3) | 85 (39.9) | |
| Adjuvant hormone therapy | |||
| Yes | 50 (70.4) | 137 (64.3) | 0.348 |
| No | 21 (29.6) | 76 (35.7) | |
| Palliative chemotherapy | |||
| Yes | 10 (14.1) | 19 (9.6) | 0.295 |
| No | 61 (85.9) | 179 (90.4) | |
| Palliative radiotherapy | |||
| Yes | 9 (12.7) | 21 (10.6) | 0.635 |
| No | 62 (87.3) | 177 (89.4) | |
| Palliative hormone therapy | |||
| Yes | 4 (5.6) | 22 (11.1) | 0.18 |
| No | 67 (94.4) | 176 (88.9) | |
*
Differences in the frequency of variables are due to missing information; Column percentages are presented; Statistically significant differences are highlighted in bold.